Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Metro Healthcare Indonesia Tbk
CARE
Sector: Healthcare
Industry: Healthcare Providers
Sub Sector: Healthcare Equipment & Providers
Sub Industry: Healthcare Providers
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
0
ROE
0,15%
ROA
0,11%
Book Value
91
Net Income
2,31 M
Total Sales
211,42 M
Total Assets
4,16 T
DER
0.37x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
14,42%
ANUGRAH KASIH RAJAWALI, PT 🔗
49,92%
Corporate · Lokal
BANK JULIUS BAER & CO. LTD 🔗
16,97%
Private Bank · Asing
CAPITAL LIFE SYARIAH, PT 🔗
4,89%
Insurance · Lokal
PT SEJAHTERA MAHKOTA PERSADA 🔗
3,51%
Corporate · Lokal
LGT BANK AG 🔗
3,01%
Private Bank · Asing
BANK OF SINGAPORE LIMITED 🔗
2,27%
Private Bank · Asing
PT. ARIMA KARYA PERSADA 🔗
1,82%
Corporate · Lokal
TJANDRA MINATA SUTIONO 🔗
1,09%
Individual · Lokal
SUMBER TEKNOLOGI MULIA, PT 🔗
1,08%
Corporate · Lokal
WELLINGTON INVESTMENTS PTE.LTD 🔗
1,02%
Investment Advisors · Asing
Tentang Perusahaan
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Produk & Lini Bisnis
The Company is engaged in management consulting services and investing inSubsidiaries.
Dewan Direksi
IH
Ir. Henry Kembaren, MM
President Director
DD
dr. Dedi Tedjakusnadi, MARS
Director
Dewan Komisaris
DA
dr. Agustinus Widjaja, C.Ht
President Commissioner
DR
dr. Rico Novyanto, Sp.PD
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
Direct Owners
 %
PT Metro Global Medika
Hospital activities, private clinics
 Tangerang 99.99%
PT Metro Helathcare Technologies
Hospital activities, private clinics
 Tangerang 99.99%
PT Metro Medika Abadi
Trading
 Jakarta 99.99%
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
440jt 330jt 220jt 110jt 0 Sales 2025Q2: Rp 158.039.817 Net Income 2025Q2: Rp 1.263.348 2025Q2 Sales 2025Q3: Rp 235.263.017 Net Income 2025Q3: Rp 2.313.117 2025Q3 Sales 2025Q4: Rp 439.751.605 Net Income 2025Q4: Rp 4.952.718 2025Q4 Sales 2026Q1: Rp 120.221.255 Net Income 2026Q1: Rp 140.691 2026Q1 Sales 2026Q2: Rp 211.419.653 Net Income 2026Q2: Rp 2.310.356 2026Q2
2025 Q2
EPS 0
ROE 0,08%
2025 Q3
EPS 0
ROE 0,10%
2025 Q4
EPS 0
ROE 0,16%
2026 Q1
EPS 0
ROE 0,02%
2026 Q2
EPS 0
ROE 0,15%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 211,42 M 2,31 M 4,16 T 3,02 T 0 0,15% 0.37x
2026 Q1 120,22 M 140,69 Jt 4,17 T 3,02 T 0 0,02% 0.38x
2025 Q4 439,75 M 4,95 M 4,18 T 3,02 T 0 0,16% 0.38x
2025 Q3 235,26 M 2,31 M 4,19 T 3,02 T 0 0,10% 0.39x
2025 Q2 158,04 M 1,26 M 3,90 T 3,02 T 0 0,08% 0.29x
Trend Harga Penutupan & Book Value — hover titik untuk detail
Close Price Book Value
739 570 400 231 61 Book Value 2025Q2: Rp 91 Close 2025Q2: Rp 236 2025Q2 Book Value 2025Q3: Rp 91 Close 2025Q3: Rp 290 2025Q3 Book Value 2025Q4: Rp 91 Close 2025Q4: Rp 680 2025Q4 Book Value 2026Q1: Rp 91 Close 2026Q1: Rp 410 2026Q1 Book Value 2026Q2: Rp 91 Close 2026Q2: Rp 414 2026Q2
2025 Q2
Close 236
BV 91
ROA 0,06%
2025 Q3
Close 290
BV 91
ROA 0,07%
2025 Q4
Close 680
BV 91
ROA 0,12%
2026 Q1
Close 410
BV 91
ROA 0,01%
2026 Q2
Close 414
BV 91
ROA 0,11%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 414 91 0,11%
2026 1 410 91 0,01%
2025 4 680 91 0,12%
2025 3 290 91 0,07%
2025 2 236 91 0,06%
Data diperbarui pada: 2026-05-12 10:01:54